STEWARTVILLE, Minn., Sept. 3 /PRNewswire-FirstCall/ -- Rochester Medical Corporation today announced the introduction of its Strata brands of Foley catheters. This new Foley product line features proprietary comfort layered technology. The company’s StrataSI(TM) catheter is all-silicone, while the StrataNF(TM) version includes a nitrofurazone anti-infective matrix within the silicone.
Comfort is the primary area of focus for the StrataSI(TM) and StrataNF(TM) products; the improved silicone design consists of a soft, pliable inner core surrounded by ultra-soft, ultra-smooth outer layers. The new structure allows for softness and flexibility never before seen in an all-silicone catheter. The StrataNF(TM) catheter provides the gentle feel of StrataSI(TM) along with anti-infection properties that are clinically proven to reduce bacterial CAUTI.
“The launch of StrataSI(TM) will give clinicians and patients broader access to superior latex-free alternatives. Our sales force is proud and excited to be introducing this market changing line of products,” commented Martyn Sholtis, Rochester Medical’s Corporate Vice President.
About Rochester Medical
More information about Rochester Medical is available on its website at http://www.rocm.com.
This press release contains forward-looking statements that involve risks and uncertainties, including the uncertainty of estimated revenues and profits, as well as the uncertainty of market acceptance of new product introductions, the uncertainty of gaining new strategic relationships or locating and capitalizing on strategic opportunities, the uncertainty of timing of private label sales revenues (particularly international customers), FDA and other regulatory review and response times, and other risk factors listed from time to time in the Company’s SEC reports and filings, including, without limitation, the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended September 30, 2007.
Rochester Medical Corporation
